Dojo is a tech platform that connects BAME (Black, Asian and Minority, Ethnic) students and professionals with like-minded peers and mentors. Backed by a group of distinguished advisors, including Sceenic, LinkedIn, and Mckinsey, Dojo is reimagining career development and is on a mission to deal with diversity and inclusion by democratising access to mentorship across the globe. Dojo has also been a participant in the ZINC VC tech-for-good incubator. With the proceeds, the company will tackle key hires and execute on strategic partnerships.
days to go:
Expired
investment:
£24,700
Drone Ag makes farming more productive with limited environmental impact through a new and practical approach to AI technology and drone automation. In the past three years, it has provided hardware and market-leading training to its clients such as Syngenta, Yara, agronomy firms and farmers. Additionally, Drone Ag has also worked closely with institutions such as Harper Adams University. Its training courses are LANTRA certified and BASIS registered. This company has already launched a trial application with which over 200 farmers are working, and agronomists have signed up to test it. Once launched, the commercial version will operate as SaaS and run two subscription tiers, for farmers and crop consultants. With the proceeds, it is aiming to develop full AI integration and live mapping that exports to farm machinery, permitting targeted applications only where needed.
days to go:
Expired
investment:
£298,770
Elifinty is the first smart user-friendly money application that helps people in controlling their finances and find their financial problems. This Artificial Intelligence enhanced service provides short-term solutions such as connecting the user to the right support. It also provides long-term improvement in financial management. The application is building a network of partnerships including banks, charities, government agencies and credit unions to help more people. Elifinty aims at bridging the gap between all stakeholders by providing benefit for all. With the proceeds, the company will further develop the platform and reach out for more partners.
days to go:
Expired
investment:
£99,450
ETCHO address the impact gap between investment products, wealth advisers, and end investors by providing tools to meet investor demands for impact solutions. Through a digitally friendly SaaS-base platform, they offer an impact suitability questionnaire, a proprietary inpact matching algorithm, and a research portal, helping advisers understand client suitability and recoomend aligned investments in a way that clients can easily understand and engage with.
days to go:
Expired
investment:
£300,000
Fame Media Tech (FMN) is a Software-as-a-Service (SaaS) technology start-up that aims to transform the visitor, fan, and customer experience through technology-driven data perspectives. FMN asserts that sport and hospitality sectors have suffered from customer and fan isolation during COVID-19. FMN application, n-gage.io, addresses this situation. The company argues that its portal, combined with storytelling and innovation in digital media, can help companies to positively influence user behaviour, enhance engagement, and improve loyalty. FMN claims that companies can judge the above metrics through data diagrams on its portal as well. The company's early-stage proof of concept discussions extend across sport, hospitality, and visitor attractions such as Wembley Park and Bohemians FC. FMN's exit strategy would be via a trade sale to a media or technology business.
days to go:
Expired
investment:
£45,700
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go:
Expired
investment:
£62,770
GoInStore is a first person shopping experience that allows online visitors to experience a store as if they were in the store. You are able to engage with a retail associate from that store in real-time via a one-way video stream and a two-way audio connection.
days to go:
Expired
investment:
Withheld
Goldilock empowers remote, instant control of physical connections and disconnections for assets, devices, data, and network segments – all without internet dependency. Addressing the vulnerabilities of the Cloud and emerging technologies, Goldilock provides a solution that leverages physical disconnection, offering heightened cybersecurity. With the endorsement of experts like Gregory Akers from CISCO, Goldilock excels in securing IP-based network components, achieving unmatched security through on-demand isolation or connection that remains unseen by cyber threats.
days to go:
Expired
investment:
£200,000
HOMYHUB is a multi-award winning startup that aims to unleash the full potential of garages. Customers get full access to their smart garages via smartphones that work as Smart Garage Remotes. The startup has successfully piloted a delivery service in partnership with Correos, Spain's courier service giant, resulting in a commercial contract and interest from other big brands. It has already raised €150,000+, developed and tested the full-product. HOMYHUB has also received recognition from Santander Bank, Digital Logistics, and Porsche, and has featured in publications like Voz Populi and El País. HOMYHUB is ready to launch a commercial project and scale it through marketing, key hirings, and productions which are enough to reach more than 300,000 garages starting from Spain to the rest of Europe.
days to go:
Expired
investment:
£406,760
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go:
Expired
investment:
£357,179
